Bevirimat
CAS: 174022-42-5
Ref. 3D-ZGA02242
1mg | 188,00 € | ||
2mg | 337,00 € | ||
5mg | 440,00 € | ||
10mg | 704,00 € | ||
25mg | 1.123,00 € |
Información del producto
- (3β)-3-(3-Carboxy-3-methyl-1-oxobutoxy)lup-20(29)-en-28-oic acid
- 3-O-(3′,3′-Dimethylsuccinyl)betulinic acid
- 3beta-(3-Carboxy-3-methylbutanoyloxy)lup-20(29)-en-28-oic acid 3β-(3-Carboxy-3-methylbutyryloxy)lup-20(29)-en-28-oic acid O-(3,3-Dimethylsuccinyl)betulinic acid
- Bevirimat Dimeglumine
- Fh 11327
- Lup-20(29)-en-28-oic acid, 3-(3-carboxy-3-methyl-1-oxobutoxy)-, (3β)-
- Mp 4326
- O-(3,3-Dimethylsuccinyl)betulinic acid
- Pa-457
- Yk-Fh312
- Ver más sinónimos
Bevirimat is a potent, selective and orally active inhibitor of protein-protein interactions. It has been shown to inhibit the interaction between Kv1.3 potassium channels and their ligands, which are important for the regulation of neuronal excitability. Bevirimat can also be used as a research tool to study protein interactions or as an antibody to study cell biology. Bevirimat is highly pure and stable in storage. It is not toxic to mammalian cells at concentrations below 0.5 μM and it does not inhibit non-Kv1 potassium channels at concentrations up to 10 μM.
Propiedades químicas
Consulta técnica sobre: 3D-ZGA02242 Bevirimat
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.